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Background. HIV/AIDS affects all sectors of the population and the defence forces are not exempt. A national survey was
conducted in all public and private sectors in Malawi that provide antiretroviral therapy (ART) to determine the uptake of ART by
army personnel, their outcomes while on treatment, and the impact of ART on mortality in the Malawi Defence Force.
Methodology/Principal Findings. A retrospective cohort analysis was carried out, collecting data on access and retention on
treatment from all 103 public and 38 private sector ART clinics in Malawi, using standardised patient master cards and clinic
registers. Observations were censored on December 31
st 2006. Independent data on mortality trends in army personnel from all
causes between 2002 and 2006 were available from army records. By December 31
st 2006, there were 85,168 patients ever started
on ART in both public and private sectors, of whom 547 (0.7%) were army personnel. Of these, 22% started ART in WHO clinical
stage 1 or 2 with a CD4-lymphocyte count of #250/mm
3 and 78% started in stage 3 or 4. Treatment outcomes of army personnel
by December 31
st 2006 were:2365 (67%) alive and on ART at their registration facility, 98 (18%) transferred out to another facility,
71 (13%) dead, 9 (2%) lost to follow-up, and 4 (,1%) stopped treatment. The probability of being alive on ART at 6-, 12- and 18-
months was 89.8%, 83.4% and 78.8% respectively. All-cause mortality in army personnel declined dramatically over the five year
period from 2002–2006. Conclusion/Significance. There has been a good access of army personnel to ART during the last five
years with excellent outcomes, and this should serve as an example for other defence forces and large companies in the region.
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INTRODUCTION
Malawi has been scaling up antiretroviral therapy (ART) since 2004,
and good progress has been made [1]. Treatment is available free of
charge in the public sector, and can also be obtained at a subsidised
rate from the private sector. Data on all ART patients in both public
and private sectors are recorded using a standardised system for
monitoring casefinding andtreatmentoutcomes[2],andthisincludes
information on occupation. The system is rigorously supervised every
three months [3], and the data can be considered nationally complete
and reliable, offering the opportunity to examine uptake, retention in
therapy and survival for subgroups of the population.
The Malawi Defence Force has been affected by the HIV
epidemic in the same way as the rest of the population. Before
national scale up of ART started, some infected army personnel were
offered ART, the drugs paid for from the Defence Force Budget.
When ART scale up started in 2004, three army medical clinics were
included in the first round of sites, and a fourth army clinic was added
in mid-2005. Army personnel, their families and the surrounding
catchment population can receive free ART from any of these four
clinics as well as from any public or private sector site in the country.
Given the importance of maintaining healthy personnel in the
country’s defence force, we were interested to know how many
army personnel had accessed ART, their outcomes while on
treatment, and whether ART had had any impact on mortality
rates in general in the Defence Force.
METHODS
Background
From June 2004 onwards, ART was made free within the public
sector and national roll-out started. The details have been
previously reported [2], and are only briefly described. A simple,
standardised approach is used which focuses on:- one generic,
fixed dose combination treatment (stavudine, lamivudine, nevir-
apine); a standardised system of registration, monitoring and
reporting of cases and outcomes; and quarterly monitoring and
supervision visits to all ART sites. Adult patients are eligible for
ART if they have a positive HIV test, understand the implications
of therapy, and are assessed in WHO clinical stage 3 or 4 or have a
CD4-lymphocyte count ,250 cells/mm
3 [4,5]. Because of a
shortage of CD4-count measuring capacity in the country, most
patients are started on ART based on clinical criteria only.
Patients are seen at two weeks after ART initiation and then
routinely every month for clinical assessment and ART-dispens-
ing. Patients with drug side effects are changed to alternative ART
regimens with zidovudine and/or efavirenz.
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master card for each patient and one ART register per facility
[2,3]. At enrolment, patient demographics, occupation, stage
defining conditions and clinical stage are recorded on the master
card and copied into the register. At every ART visit, follow-up
details with their dates are entered in the master card, and these
include transfer to another ART clinic, treatment discontinuation
and death. Patients who fail to return for 3 months are marked as
‘lost to follow-up’. Although active follow-up of patients who fail to
return to clinic has not been made mandatory due to resource
constraints, more than half of the facilities in the national
programme are consistently attempting to trace these patients
through community visits. A patient cohort analysis is conducted
at all sites every quarter, with clinic staff systematically reviewing
and updating the latest follow-up status of all patients. The HIV
Unit of the Ministry of Health and its partners conduct quarterly
supervision and monitoring visits to all ART sites in the country.
The supervisors check the accuracy, completeness and consistency
of the register and master cards. Cohort analyses are checked and
collected for aggregation and national level reporting.
A similar monitoring and supervisory system is used in the
private sector, with the same monitoring tools and same quarterly
supervision conducted by a clinical officer employed by the
Malawi Business Coalition against AIDS. The only difference
being that patients have to pay the equivalent of USD$3 per
month for their ART, and this payment is similar regardless of the
type of regimen.
Data Collection and Analysis
The survey was conducted during supervision visits to all 103 public
sector ART clinics and 38 private sector clinics, which took place
between January and March 2007. In addition to the routine
collection of data, all ART clinic registers and master cards were
screened for army personnel who had accessed ART up to
December 31
st 2006. For all army personnel identified, the following
data were transcribed onto a structured form: site-specific registra-
tion number; sex; date, age and WHO clinical stage at ART
initiation; date and type of follow-up outcome. The data were
checked, entered and cleaned in MS Access and analysed using
STATA 9.2. Observations were censored if patients were alive and
on ART by 31
st December 2006. Adverse outcomes of death, lost to
follow-up and ART discontinuation were regarded as ‘failure events’
and their dates were recorded, while transfers to other ART clinics
were regarded as censoring events and their dates were also
recorded. Categorical variables between army personnel and non-
army personnel were analysed and compared using the chi squared
test with odds ratios (OR). The probability of survival on ART was
estimated using the Kaplan-Meier method. The level of significance
for all comparisons was set at P=0.05 or less, and 95% confidence
intervals (CI) were used throughout.
Details were obtained at the 4 army ART clinics and all the
other non-army ART clinics on the number of days in a week the
clinic operated, the number of clinicians and nurses operating the
clinic, drug stocks, and, in the last quarter of the year, drug
adherence of patients alive and on ART. Drug adherence is
assessed by ART staff every quarter by doing pill counts, with
good drug adherence being equal to 95% or more of pills taken
against the number that should have been consumed [5].
To measure the impact of ART on survival in the Malawi
Defence Force, data on deaths amongst all army personnel in the
country were obtained from the annual register of deaths in army
personnel, which is maintained at the main army barracks in
Lilongwe. The number of deaths each year for the last 5 years was
documented.
Ethical approval
General measures are provided in all ART facilities to ensure
patient confidentiality, consent for HIV testing, and counselling
and support for those who receive a positive HIV test result. Data
for this study collected from ART sites and army records did not
include any personal identifiers. The Malawi National Health
Science Research Committee provides general oversight and
approval for the collection and use of routine programmatic data
for monitoring and evaluation, as was the case with this study.
Formal ethical approval was therefore not required.
RESULTS
General national patient cohort
ByDecember 31
st2006,a total of 81,821patientshad accessedART
at 103 public sector ART facilities in Malawi. Of these, 50,162
(61.3%) were female and 76,058 (93.0%) were aged 15 years or
above. There were 9,833 (12%) patients started on ART in WHO
clinical stage 1 or 2 with a CD4 count #250/mm
3, and 71,988
(88%) started in stage 3 or 4. A total of 3,347 patients had accessed
ART at 38privatesectorART facilities bythe end of 2006.Ofthese,
1,635 (48.8%) were female and 3,201 (95.6%) were aged 15 years or
above. There were 1,143 (34%) patients started on ART in WHO
clinical stage 1 or 2 with a CD4 count #250/mm
3,a n d2 , 2 0 4( 6 6 % )
started in stage 3 or 4. Treatment outcomes by end of December
2006 are shown in Table 1. The routine quarterly cohort treatment
outcomes in the public sector showed that 74% of 10,608 patients
and 61% of 7,871 patients were alive and on ART at 6 and
12 months after enrolment respectively.
Army Personnel
Information on occupation was available for 82,297 (96.6%) patients
in the national public and private sector cohort. There were 547
army personnel (0.7%), 526 men and 21 women. The mean age at
ART initiation was 39 (range 24–65) years. Army personnel had
accessed ART from 37 facilities; 543 army personnel had accessed
ART from 34 sites in the public sector and 4 army personnel had
accessed ART from 3 sites in the private sector; 406 (74%) of the
patients were managed at the four army clinics.
Demographic and clinical details of army personnel and non-
army personnel (the latter from the public sector) are shown in
Table 2. There were significantly more males started on ART in
the army compared with the general population. Significantly
more army personnel accessed ART due to being in WHO clinical
stage 1 or 2 with a CD4 count #250/mm
3 compared with the
Table 1. National treatment outcomes of patients enrolled to
antiretroviral therapy (ART) in the public sector, private sector
and both sectors combined together, with outcomes
censored on December 31
st 2006
......................................................................
Public Sector Private Sector Both sectors
Patients enrolled 81,821 3,347 85,168
Alive and on therapy 57,356 (70%) 2,624 (78.4%) 59,980 (70.4%)
Dead 9,327 (11.4%) 222 (6.6%) 9,549 (11.2%)
Lost to follow-up (not seen
at the clinic for 3 months)
7,753 (9.5%) 132 (3.9%) 7,885 (9.3%)
Stopped therapy 365 (0.5%) 7 (0.3%) 372 (0.4%)
Transferred out to another
ART site
7,020 (8.6%) 362 (10.8%) 7,382 (8.7%)
doi:10.1371/journal.pone.0001445.t001
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due to clinical illness there were more army personnel in WHO
clinical stage 4.
The median observation time for the whole army cohort was
11.1 months (range 0.1 to 71 months), and the entire cohort had
accumulated 596 person-years of observation. Treatment out-
comes in army personnel by the end of December 2006 in army
personnel are shown in Table 2, and are again compared with
outcomes in non-army personnel in the public sector. There was a
higher transfer out rate and a lower loss to follow-up rate amongst
army personnel compared with the general population, but
retention on therapy, deaths and stoppages of treatment were
similar between the two groups. The number of army personnel
retained alive and on ART by calendar period and the number of
army personnel who died each year during the last 5 years is
shown in Figure 1. The probability of being alive and on ART at
6, 12 and 18 months was 89.7%, 83.5%, and 78.5% respectively.
The 4 army ART clinics managed patients on an average of
3.0 days per week, similar to that seen in the 99 non-army clinics
in the public sector (3.0 days per week). A total of 5 clinicians (1.25
per clinic) and 6 nurses (1.5 per clinic) provided services in the
army clinics on the days they were open: this was similar to the 99
non-army clinics where a total of 150 clinicians (1.5 per clinic) and
155 nurses (1.5 per clinic) provided services. Of all patients alive
and on ART in the army clinics in whom pill counts were done
(n=922, which includes army personnel and their relatives), 896
(97.2%) showed good drug adherence: this was significantly higher
than that observed in patients alive and on ART in non-army
clinics where 34,771 (92.7%) of 37,504 showed good drug
adherence [OR 2.7, 95% CI 1.8–4.1, p,0.001]. Since national
ART scale up started in Malawi, there have been no stock-outs of
ART drugs in any facility, including the army clinics.
During 2002, before the start of the ART programme, there
were 153 deaths among army personnel. In 2006, while staff
numbers had remained similar, annual deaths had dropped to 36
(Figure 1). This represents a dramatic 76% reduction in all-cause
mortality between 2002 and 2006.
DISCUSSION
We believe that this is the first national survey in Sub-Saharan
Africa of army personnel on ART examining uptake, retention on
therapy and the impact that this has had over the last 5 years in
reducing death rates. By the end of 2006, a total of 547 army
personnel had been started on ART, the majority from the 4 army
clinics that provide ART in Malawi. These army clinics operate on
average the same number of clinic days per week and have the
same ART clinic staffing complement as the other clinics around
the country, and no clinic has experienced an ART drug stock out
since national scale up started in 2004.
Table 2. Demographic, clinical features and treatment
outcomes censored on December 31
st 2006 in army personnel
and non-army personnel starting free ART in the public sector
in Malawi
......................................................................
Army
personnel
Non-army
personnel
Odds ratio
(95% CI)
*
Number 547 81 274
Males 526 (96.2%) 31 133 (38.3%) 40.3 [25.6–64.1]
Reasons for starting ART:
WHO stage 1 and 2 119 (21.8%) 9 714 (12.0%) 2.1 [1.7–2.5]
WHO stage 3 248 (45.3%) 52 782 (64.9%) 0.45 [0.4–0.5]
WHO stage 4 180 (32.9%) 18 778 (23.1%) 1.6 [ 1.4–2.0]
Outcomes by December 2006
Alive on ART at the clinic 365 (66.7%) 56 991 (70.1%)
Transferred out to another
clinic
98 (17.9%) 6 922 (8.5%) 2.3 [ 1.9–2.9]
Dead 71 (13.0%) 9 256 (11.4%)
Lost to follow-up 9 (1.6%) 7 744 (9.5%) 0.2 [0.1–0.3]
Stopped therapy 4 (0.2%) 361 (0.5%)
*Odds ratios shown for significant results only (p,0.05)
doi:10.1371/journal.pone.0001445.t002
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Figure 1. Number of army personnel alive and on antiretroviral therapy and the annual number of deaths of army personnel: 2002–2006.
doi:10.1371/journal.pone.0001445.g001
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ART from public sector sites on several counts: there were more
males; more patients started on ART due to being in stage 1 and 2
with a low CD4 count and due to being in WHO clinical stage 4;
there was a low default rate and a higher transfer-out rate; and
survival probabilities, at least up to 12–18 months were higher
than for the general population. The findings in fact are more
similar to those seen in the private sector in Malawi, and are not
surprising. The majority of army personnel in Malawi are male.
Because the main army clinics are situated in cities, there is
relatively good access to laboratories that can perform CD4-
lymphocyte tests and this may be one of the main reasons why a
higher proportion of army personnel start ART due to being in
WHO clinical stage 1 and 2. Why more army personnel start ART
due to being in WHO clinical stage 4 is not known, but this may
reflect a more comprehensive clinical assessment of patients. The
Defence Force can maintain good follow-up of its patients, hence
the low default rate. There was a high transfer rate due to frequent
postings to different parts of the country. Recent operation
research in Malawi (Yu, unpublished observations) shows that the
majority of patients who transfer-out do in fact transfer-in at
another site, and most of these patients subsequently stay alive and
on therapy. Survival probabilities are good, probably due to larger
numbers of the Defence Force accessing ART at an earlier stage of
HIV disease and possibly due to the higher measured drug
adherence in patients attending army clinics compared with that
seen in the general population.
Without ART, HIV-infected patients assessed in WHO clinical
stage 3 or 4 have a very poor prognosis in Malawi [6], while on
ART the prognosis is transformed. Without the national ART
program, it is likely that annual death rates in the army would
have continued to increase over the last 5 years. With the ever
increasing number of army personnel retained alive on treatment,
this trend has been impressively reversed. This is corroborated by
the 76% reduction in all-cause mortality between 2002 and 2006,
which was observed independently in army staff records. It is likely
that other occupational groups have benefited from a similar
impact [7].
This operational study was based on data from the routine
national monitoring system, and therefore has some limitations.
Occupation was unknown for about 3% of patients, and this may
have lead to a small undercounting of the number of army
personnel who accessed ART in the country. It is also possible that
some patients felt uncomfortable registering as a member of the
Malawi Defence Force in ART clinics outside of the army health
services, and may have given a different occupation to ART clinic
staff. The average observation time of the national cohort of army
personnel is still relatively short, and longer term outcomes could
not be reliably assessed. The strengths of the study are that this is a
full national survey, all ART-providing facilities in the public and
private sector of Malawi were included, and the analysis is likely to
provide near-complete information on all army personnel who
have accessed treatment in the country, provided that they have
been accurately recorded in the occupation column of the register.
Malawi has established a standard, national monitoring system for
ART used by all public and private sector facilities, the data are
routinely validated during quarterly supervision through cross-
checking of master cards and ART registers, ensuring high data
quality. Occupation was available for 97% of patients and
assuming that recording was accurate, the survey is likely to
provide near-complete information on all army personnel started
on ART in Malawi.
The Malawi Defence Force has shown outstanding leadership in
its management of HIV/AIDS. First, it provided at its own
expense ART for its personnel before the national scale up
commenced. Second, it was pro-active in its desire to be part of the
national ART scale up, with army medical personnel participating
in the development and implementation of national plans and the
national training curriculum. The four army clinics provide
therapy to the majority of army personnel, and through a
disciplined approach to follow-up the army has achieved excellent
treatment outcomes. This approach should serve as an example to
other defence forces in the world, as well as large companies in
both the private and public sector.
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